Sandra Sigala
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 09, 2025
Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 23, 2025
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma.
Journal: European journal of endocrinology
Published: November 17, 2025
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 11, 2025
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma.
Journal: European journal of endocrinology
Published: September 09, 2025
Updating ACC preclinical models: characterization of two new patient-derived cell lines.
Journal: Endocrine-related cancer
Published: August 19, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2025
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models.
Journal: Scientific reports
Published: June 13, 2025
Cancer cell xenografts in zebrafish embryos as an experimental tool in drug screening for adrenocortical carcinoma.
Journal: Minerva endocrinology
Published: February 25, 2025
(Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma.
Journal: Experimental & molecular medicine
Published: December 30, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.
Journal: Cancer communications (London, England)
Published: November 20, 2024
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.
Journal: Cell communication and signaling : CCS
Published: October 08, 2024
Last Updated: 09/26/2026